Carl Zeiss Meditec AG
- WKN: 531370
- ISIN: DE0005313704
- Land: Deutschland
Nachricht vom 11.05.2020 | 07:00
Carl Zeiss Meditec increases revenue in first six months of 2019/20
DGAP-News: Carl Zeiss Meditec AG
/ Key word(s): Half Year Results
JENA, Monday, May 11, 2020
Carl Zeiss Meditec generated revenue of €714.9m in the first six months of 2019/20 (prior year: €667.2m), achieving growth of 7.2% (adjusted for currency effects: +5.8%) compared with the same period of the prior year. Earnings before interest and taxes (EBIT) decreased slightly to €102.5m (prior year: €110.4m). The EBIT margin was 14.3% (prior year: 16.5%).
"Our revenue growth in the first six months of the year is the result of basically solid demand for our products and solutions" says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. "However, we, too, were significantly impacted by the effects of the COVID-19 pandemic during the second quarter, which was initially evident in the Asia/Pacific region and was then also abundantly clear in Europe and North America in March."
Growth in both strategic business units
Revenue in the Ophthalmic Devices strategic business unit (SBU) increased by 5.5 percent in the first six months of fiscal year 2019/20 (adjusted for currency effects: +4.2 percent), to €517.7m (prior year: €490.7m).
Continued growth in Americas and APAC
Revenue in the EMEA region decreased by 2.3 percent (adjusted for currency effects: -2.3 percent), to €208.7m (prior year: €213.7m). In March, in particular, incoming orders decreased in this region, due to the effects of the COVID-19 pandemic.
The Americas region increased its revenue by 13.6 percent after the first six months of the current fiscal year (adjusted for currency effects: 10.8 percent), to €205.5m (prior year: €180.9m). The U.S. achieved good growth, although there was also a significant downturn in this region in March compared with the prior year.
The APAC region also made a positive contribution to growth, bolstered by a robust trend in Japan and South Korea, increasing revenue by 10.3 percent (adjusted for currency effects: +8.8 percent) to €300.7m (prior year: €272.6m). In China, however, in particular, temporary closures of clinics and postponements of non-acute surgical treatments in February and March resulted in substantial losses of revenue.
Operating earnings slightly down versus previous year
The operating result (earnings before interest and taxes: EBIT) fell slightly in the first six months of fiscal year 2019/20, to €102.5m (prior year: €110.4m). The EBIT margin decreased from 16.5 percent to 14.3 percent. Adjusted for special effects, this amounted to 14.7 percent (prior year: 16.8 percent). Earnings per share increased to €0.71 (prior year: €0.65), since losses on currency hedging transactions were significantly lower compared with the prior year.
"As we already communicated at the start of April, we are currently unable to give an exact forecast for the rest of fiscal year 2019/20, due to the global effects of the COVID-19 pandemic. Our priority at the present time is the safety of our employees and maintaining production operations and service in order to support our customers in the best possible way," says Dr. Ludwin Monz.
Revenue by strategic business unit
Revenue by region
Contact for investors and press
|Company:||Carl Zeiss Meditec AG|
|Göschwitzer Str. 51-52|
|07745 Jena, Germany|
|Phone:||+49 (0)3641 220-0|
|Fax:||+49 (0)3641 220-112|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1040503|
|End of News||DGAP News Service|
Successful start to FY 2020/21 for Carl Zeiss ...
Carl Zeiss Meditec AG: Preliminary announcemen ...
Carl Zeiss Meditec AG achieves increase in pro ...
Carl Zeiss Meditec AG: Release according to Ar ...
Carl Zeiss Meditec reports decline in revenue ...
Event im Fokus
10. Juni 2021:Fachkonferenz Immobilien
14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure
13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie
10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix
„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“
11 Perlen im „GBC Fonds Champions 2021“
Im Rahmen der aktuellen Studie „GBC Fonds Champions 2021“ haben wir elf versteckte Fondsperlen mit dem Kriterium einer Mindestbewertung von 4 von 5 GBC-Falken ausgewählt. Auch tragen wir dem gesteigerten Investoreninteresse nach nachhaltigen Investments Rechnung und haben drei nachhaltige Fonds ausgewählt. Übrigens, die Fonds aus unserer letzten Ausgabe haben im Schnitt eine Performance von plus 31,8 % erreicht.
Der AKTIONÄR News
17. April 06:00 Nel und ITM Power: Jetzt meldet sich Morgan Stanley zu Wort
16. April 18:55 Coinbase: Diese Kursziele sind der Hammer
16. April 18:19 Airbnb: Luxusproblem ala Uber
News im Fokus
Vonovia SE: Aktionäre beschließen auf Hauptversammlung Dividende von 1,69 Euro (News mit Zusatzmaterial)
16. April 2021, 16:41
Conference Call 11.05.2021 (Webcast)
11. Mai 2021
Original-Research: Mountain Alliance AG (von Montega AG): Kaufen
16. April 2021